Despite numerous leaks about impending changes to medicines policy, the budget showed savings of just $252.2 million over five years from adjusting the price of a small number of PBS-listed drugs.
Academic rigor, journalistic flair
Articles on Medicines Australia
Displaying all articles
The Australian Competition and Consumer Commission (ACCC) is considering whether to approve the latest Medicines Australia code of conduct for pharmaceutical companies. The code lays out disclosure requirements…
The Australian Medical Association (AMA) and medical specialist groups are currently debating public disclosure of gifts received by doctors from pharmaceutical companies. The bone of contention is how…
Two bills in the national parliament provide a snapshot of our health regulatory system, and just like a smoker’s lungs, it’s not a pretty picture. The bills show that we’re slow in fixing regulatory incapacity…
It takes a lot of bravery for governments to stand up to big business. But the Gillard government has shown a lot of guts during its tenure. It stood up to Big Tobacco in the battle over plain packaging…
Top contributors
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Professor of Bioethics, Macquarie University
-
Health activist, Medreach Pty Ltd., Bond University
-
Associate Professor of Law, Bond University
-
Professor of Health Economics, The University of Melbourne
-
Professor in Intellectual Property and Innovation Law, Queensland University of Technology
-
Associate Professor, School of Law, University of Canberra
